Financials data is unavailable for this security.
View more
Year on year Biofil Chemicals and Pharmaceuticals Ltd grew revenues 33.29% from 300.35m to 400.35m while net income improved 26.55% from 5.60m to 7.09m.
Gross margin | 4.94% |
---|---|
Net profit margin | 1.38% |
Operating margin | 0.69% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Biofil Chemicals and Pharmaceuticals Ltd increased its cash reserves by 5,973.14%, or 22.46m. The company earned 23.94m from its operations for a Cash Flow Margin of 5.98%. In addition the company used 229.00k on investing activities and also paid 1.25m in financing cash flows.
Cash flow per share | 0.6445 |
---|---|
Price/Cash flow per share | 132.74 |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 26.55%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years) | 8.02 |
---|---|
EPS (TTM) vs TTM 1 year ago | 10.56 |